Impact of herpes zoster and post-zoster SGLT2 inhibitors initiation on cardiorenal outcomes in type 2 diabetes mellitus.
Saved in:
| Title: | Impact of herpes zoster and post-zoster SGLT2 inhibitors initiation on cardiorenal outcomes in type 2 diabetes mellitus. |
|---|---|
| Authors: | Wu MZ; Department of Geriatrics, National Key Clinical Specialty, School of Medicine, The Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), Guangzhou, China.; Division of Cardiology, Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; Division of Cardiology, Department of Medicine, The University of Hong Kong, Room 1928, Block K, Queen Mary Hospital, Hong Kong, China., Tsang CT; Division of Cardiology, Department of Medicine, The University of Hong Kong, Room 1928, Block K, Queen Mary Hospital, Hong Kong, China., Peng C; Department of Geriatrics, National Key Clinical Specialty, School of Medicine, The Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), Guangzhou, China., Huang JY; Division of Cardiology, Department of Medicine, The University of Hong Kong, Room 1928, Block K, Queen Mary Hospital, Hong Kong, China., Guo R; Division of Cardiology, Department of Medicine, The University of Hong Kong, Room 1928, Block K, Queen Mary Hospital, Hong Kong, China., Tse YK; Division of Cardiology, Department of Medicine, The University of Hong Kong, Room 1928, Block K, Queen Mary Hospital, Hong Kong, China., Chan YH; Division of Cardiology, Department of Medicine, The University of Hong Kong, Room 1928, Block K, Queen Mary Hospital, Hong Kong, China., Lee CH; Division of Endocrinology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China., Zhang JN; Division of Cardiology, Department of Medicine, The University of Hong Kong, Room 1928, Block K, Queen Mary Hospital, Hong Kong, China., Gu WL; Division of Cardiology, Department of Medicine, The University of Hong Kong, Room 1928, Block K, Queen Mary Hospital, Hong Kong, China., Li XL; Jiangsu People's Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China., Ren QW; Division of Cardiology, Department of Medicine, The University of Hong Kong, Room 1928, Block K, Queen Mary Hospital, Hong Kong, China., Yiu KH; Division of Cardiology, Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China. khkyiu@hku.hk.; Division of Cardiology, Department of Medicine, The University of Hong Kong, Room 1928, Block K, Queen Mary Hospital, Hong Kong, China. khkyiu@hku.hk. |
| Source: | BMC endocrine disorders [BMC Endocr Disord] 2026 Apr 15; Vol. 26 (1). Date of Electronic Publication: 2026 Apr 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101088676 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6823 (Electronic) Linking ISSN: 14726823 NLM ISO Abbreviation: BMC Endocr Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
